In Brief: revised NDI draft expected in 2013, MusclePharm invests, Sundial label and GMP warnings, AHPA publishes organic guidance

09 Sep 2013

CFSAN plans revised NDI draft in 2013; MusclePharm invests in BioZone delivery tech; Indiana kicks off anti-smurfing campaign; Sundial fails basic labeling, GMP compliance; AHPA advises supplement firms on organic rules; Naturex commits to sustainability; Targeted Medical Pharma expands into supplements.

FDA intends to publish a revised draft guidance on new dietary ingredient notifications before the end of 2013 and a final guidance in 2014, according to the Center for Food Safety and Applied Nutrition’s 2013-2014 program priorities. The list

posted Sept. 5 also notes CFSAN intends to publish a final guidance before the end of 2013 to help dietary...